MODV_OUT_1 [2025-04-29 09:29:15 -0400] 5592 Bytes | 1582 tokens | Cum: 1582 tkns (19.78% of 8k)
==========================================================================

Adventure stirs the soul. 9:29 AM on Tue Apr 29, 2025, ModivCare (MODV) is on the move—$1.40 to $1.53. Shall we explore the opportunity, or stand down? Analysis awaits.

--- COMPANY PROFILE ---
Company: ModivCare (MODV)
IPO: IPO date unknown
Shares Outstanding: 14,340,000
Industry: TRANSPORTATION SERVICES
Exchange: XNAS

Here’s a list of headlines for ModivCare:

Apr-28-25 04:05PM - Modivcare to Report First Quarter 2025 Financial Results
Apr-28-25 04:05PM 10:25AM - The 1-Minute Market Report April 27, 2025
Apr-25-25 06:30AM - Modivcare Announces Changes to Board of Directors
Apr-24-25 09:00AM - KDK Transport Company Named Modivcares Virginia Transportation Provider of the Year
Apr-23-25 09:00AM - Modivcare and Aetna Better Health of Illinois Transform Access to Healthcare in Illinois with Launch of Health Stations
Apr-17-25 07:38AM - Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Behalf
Apr-14-25 03:40PM - Aristotle Small Cap Equity Q1 2025 Commentary
Apr-13-25 10:44AM - The 1-Minute Market Report April 13, 2025
Mar-31-25 08:05AM - The 1-Minute Market Report March 30, 2025
Mar-28-25 09:24AM - MODV Shareholders Have the Right to Lead the ModivCare Inc. Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MODV
Mar-28-25 09:24AM 07:55AM - Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against ModivCare Inc. (MODV)
Mar-26-25 07:55AM - Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against ModivCare Inc. (MODV)
Mar-24-25 05:37AM - ModivCare Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights MODV
Mar-18-25 05:45AM - ModivCare Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MODV
Mar-17-25 06:34PM - MODV Shareholders Have the Right to Lead the ModivCare Inc. Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MODV
Mar-07-25 05:46AM - ModivCare Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - MODV
Mar-06-25 04:23PM - Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors
Feb-28-25 06:00AM - Modivcare to Report Fourth Quarter and Full Year 2024 Financial Results and Adjourn Special Meeting to Follow Report
Feb-28-25 06:00AM 05:45AM - ModivCare Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - MODV
Feb-23-25 08:45PM - Kessler Topaz Meltzer & Check, LLP Encourages ModivCare Inc. Investors with Losses to Contact the Firm
Feb-21-25 03:33PM - Fortrea to Add Erin L. Russell to Board of Directors
Feb-21-25 03:33PM 05:45AM - Investors in ModivCare Inc. Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - MODV

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-03-31T20:00:00Z - MODV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
B2 - 2025-03-31T14:41:00Z - DEADLINE ALERT for IAS, MODV, and TIXT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
B3 - 2025-03-29T16:38:00Z - MODV IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ModivCare Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action – MODV
B4 - 2025-03-23T13:13:00Z - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ModivCare
B5 - 2025-03-21T16:00:00Z - Deadline Alert: ModivCare, Inc. (MODV) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
B6 - 2025-03-15T17:26:00Z - ROSEN, A TOP RANKED LAW FIRM, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MODV

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for ModivCare (MODV).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

MODV_OUT_3 [2025-04-29 09:29:16 -0400] 996 Bytes | 269 tokens | Cum: 1853 tkns (23.16% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**MODV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/31/3052719/9788/en/MODV-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-ModivCare-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.htmlA class action lawsuit has been filed against ModivCare, Inc. alleging that the company made materially false and/or misleading statements about its business, operations, and prospects, which negatively impacted the company's free cash flow and adjusted EBITDA.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_5 [2025-04-29 09:29:17 -0400] 801 Bytes | 240 tokens | Cum: 2095 tkns (26.19% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-28T20:04:42Z - Modivcare to Report First Quarter 2025 Financial Results...
A2 - 2025-04-28T20:17:30Z - Modivcare to Report First Quarter 2025 Financial Results...
A3 - 2025-04-28T20:06:48Z - Modivcare to Report First Quarter 2025 Financial Results...
A4 - 2025-04-25T10:29:53Z - Modivcare Announces Changes to Board of Directors...
A5 - 2025-04-25T10:53:53Z - ModivCare Inc. (MODV) Announces Board Changes...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

MODV_OUT_7 [2025-04-29 09:29:18 -0400] 1181 Bytes | 327 tokens | Cum: 2424 tkns (30.30% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**Modivcare to Report First Quarter 2025 Financial Results**Date: 2025-04-28Source: {'uri': 'bdtonline.com', 'dataType': 'news', 'title': 'Bluefield Daily Telegraph'}URL: https://www.bdtonline.com/news/nation_world/modivcare-to-report-first-quarter-2025-financial-results/article_c24f70c0-c0da-562b-852e-ed0e015a48d6.htmlDENVER--(BUSINESS WIRE)--Apr 28, 2025--

Modivcare Inc. ("Modivcare" or the "Company") (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and intern

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_9 [2025-04-29 09:29:18 -0400] 1181 Bytes | 691 tokens | Cum: 3117 tkns (38.96% of 8k)
==========================================================================

Showing A1 (chunk 2 of 5): ational callers should dial +1 (201) 689-8037.

kAmx?E6C6DE65 A2CE:6D >2J 2=D@ 2446DD E96 =:G6 H6342DE G:2 E96 r@>A2?J'D H63D:E6 2Ei k2 9C67lQ9EEADi^^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?<U2>AjFC=l9EEADTbpTauTau:?G6DE@CD]>@5:G42C6]4@>Tau6G6?ED\AC6D6?E2E:@?DTau5672F=E]2DAIU2>Aj6D966Eldcacd_b_U2>Aj?6HD:E6>:5la_ad_cageg_cd_U2>Aj=2?l6?\&$U2>Aj2?49@Cl9EEADTbpTauTau:?G6DE@CD]>@5:G42C6]4@>Tau6G6?ED\AC6D6?E2E:@?DTau5672F=E]2DAIU2>Aj:?56Il'U2>Aj>5dl2d752cefbh63ab4f3gbbhcad55h2'56hQ C6=lQ?@7@==@HQ D92A6lQC64EQm9EEADi^^:?G6DE@CD]>@5:G42C6]4@>^6G6?ED\AC6D6?E2E:@?D^5672F=E]2DAIk^2m]k^Am

kAm%96 H6342DE 42? 2=D@ 36 2446DD65 k2 9C67lQ9EEADi^^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?<U2>AjFC=l9EEADTbpTauTauFC=]FD]>]>:>642DEAC@E64E]4@>TauDTau\D(}rs<*">$+v8=e9d9*4;f=4BTbu5@>2:?Tbs6G6?E]49@CFD42==]4@>U2>Aj6D966Eldcacd_b_U2>Aj?6HD:E6>:5la_ad_cageg_cd_U2>Aj=2?l6?\&$U2>Aj2?49@Cl96C6U2>Aj:?56IlaU2>Aj>5dlgd_53cc6

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_11 [2025-04-29 09:29:19 -0400] 1181 Bytes | 739 tokens | Cum: 3858 tkns (48.23% of 8k)
==========================================================================

Showing A1 (chunk 3 of 5): 5a_766d57hg_fedd__d_g4_5Q C6=lQ?@7@==@HQ D92A6lQC64EQm96C6k^2m]k^Am

kAmp C6A=2J @7 E96 4@?76C6?46 42== H:== 36 2G2:=23=6 @? E96 r@>A2?J'D H63D:E6 2AAC@I:>2E6=J @?6 9@FC 27E6C E96 42== 4@?4=F56D]k^Am

kAmk6>mp3@FE |@5:G42C6k^6>mk^Am

kAm|@5:G42C6 W}2D52Bi |~s'X 😀 2 E649?@=@8J\6?23=65 962=E942C6 D6CG:46D 4@>A2?J E92E AC@G:56D 2 A=2E7@C> @7 :?E68C2E65 DFAA@CE:G6 42C6 D@=FE:@?D 7@C AF3=:4 2?5 AC:G2E6 A2J@CD 2?5 E96:C >6>36CD] ~FC G2=F6\32D65 D@=FE:@?D 255C6DD E96 D@4:2= 56E6C>:?2?ED @7 962=E9 W$s@wX[ 6?23=6 8C62E6C 2446DD E@ 42C6[ C65F46 4@DED[ 2?5 :>AC@G6 @FE4@>6D] (6 2C6 2 =625:?8 AC@G:56C @7 ?@?\6>6C86?4J >65:42= EC2?DA@CE2E:@? W}t|%X[ A6CD@?2= 42C6 D6CG:46D W!r$X 2?5 C6>@E6 A2E:6?E >@?:E@C:?8 W#!|X] %96 r@>A2?J 2=D@ 9@=5D 2 >:?@C:EJ 6BF:EJ :?G6DE>6?E 😕 rrw} vC@FA w@=5:?8D[ x?4] W532 |2EC:I |65:42= }6EH@C<X[ 2 =625:?8 2?5 :?56A6?56?E ?2E:@?2= AC@G:56C @7 :?\9@>6 4@>AC696?D:G6 962=E9 2D

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_13 [2025-04-29 09:29:20 -0400] 1181 Bytes | 740 tokens | Cum: 4600 tkns (57.50% of 8k)
==========================================================================

Showing A1 (chunk 4 of 5): D6DD>6?ED] %@ =62C? >@C6 23@FE |@5:G42C6[ A=62D6 G:D:E k2 9C67lQ9EEADi^^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?<U2>AjFC=l9EEATbpTauTauHHH]>@5:G42C6]4@>U2>Aj6D966Eldcacd_b_U2>Aj?6HD:E6>:5la_ad_cageg_cd_U2>Aj=2?l6?\&$U2>Aj2?49@ClHHH]>@5:G42C6]4@>U2>Aj:?56IlbU2>Aj>5dl'7fagaghd3f4_4gh5d25'66e7ea56g56Q C6=lQ?@7@==@HQ D92A6lQC64EQmHHH]>@5:G42C6]4@>k^2m]k^Am

kAm':6H D@FC46 G6CD:@? @? k2 9C67lQ9EEAi^^3FD:?6DDH:C6]4@>Qm3FD:?6DDH:C6]4@>k^2mik2 9C67lQ9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ad_cageg_cd_^6?^Q C6=lQ?@7@==@HQm9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ad_cageg_cd_^6?^k^2mk^Am

kAmr~}%pr%i |65:2k^Am

kAmk2 9C67lQ>2:=E@i|65:2]x?BF:CJo>@5:G42C6]4@>Qm|65:2]x?BF:CJo>@5:G42C6]4@>k^2mk^Am

kAmx?G6DE@CDk^Am

kAmxr# w62=E942C6k^Am

kAmk2 9C67lQ>2:=E@i|@5:G42C6x#o:4C962=E942C6]4@>Qm|@5:G42C6x#o:4C962=E942C6]4@>k^2mk^Am

kAmzt*(~#si &}x%ts $%p%t$ }~#%w p|t#xrp r~{~#ps~k^Am

kAmx}s&$%#* zt*(~#si |p

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_15 [2025-04-29 09:29:21 -0400] 1097 Bytes | 278 tokens | Cum: 4880 tkns (61.00% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S4 - 2025-03-14 8-K Item1.01. Entry Into or Amendment of a Material Definitive Agrmt.

Purchase and Exchange Agrmt

As described in further detail in the Curr Report on Form 8-K filed with the Securities and Exchange Commission (the Commission ) on January 10, 2025 and the definitive pr...

S5 - 2025-03-11 8-K Item1.01. Entry Into or Amendment of a Material Definitive Agrmt.

Exchange Agrmt

As previously disclosed by ModivCare Inc. (the Company ) in a Curr Report on Form 8-K filed by the Company with the Securities and Exchange Commission on January 10, 2025, on January 9...

S6 - 2025-03-06 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our CONS financial statements and related notes i...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

MODV_OUT_17 [2025-04-29 09:29:22 -0400] 1181 Bytes | 293 tokens | Cum: 5175 tkns (64.69% of 8k)
==========================================================================

Showing S4 (chunk 1 of 4): S4:
Item1.01. Entry Into or Amendment of a Material Definitive Agreement.

Purchase and Exchange Agreement

As described in further detail in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the Commission ) on January 10, 2025 and the definitive proxy statement filed with the Commission on February 3, 2025 (the Proxy Statement ), pursuant to the Purchase and Exchange Agreement, dated January 9, 2025 (the Purchase and Exchange Agreement ), by and among ModivCare Inc. (the Company ) and Coliseum Capital Partners, L.P. ( CCP ) and Blackwell Partners LLC - Series A (together with CCP, the Investors ), the Investors agreed, subject to approval of the Companys stockholders at the Special Meeting (as defined below), to (i) purchase (the Purchase ) $30.0 million in aggregate principal amount of the Companys 5.000%/10.000% Second Lien Senior Secured PIK Toggle

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_19 [2025-04-29 09:29:23 -0400] 1181 Bytes | 276 tokens | Cum: 5453 tkns (68.16% of 8k)
==========================================================================

Showing S4 (chunk 2 of 4): Notes due 2029 (the Second Lien Notes ) and (ii) exchange $20.165 million in aggregate principal amount of the Companys existing 5.000% Senior Notes due 2029 held by the Investors for an equivalent principal amount of Second Lien Notes (the Exchange and, together with the Purchase, the Expense Reimbursement (as defined in the Proxy Statement), the performance by the Company of its other obligations under the Purchase and Exchange Agreement, the terms of the Second Lien Notes, the Second Lien Notes Indenture (as defined below) and any other documents incidental to the issuance of the Second Lien Notes, any other actions the Company may take in furtherance of the foregoing and the receipt by the Investors of the benefits of being holders of the Second Lien Notes, the Coliseum Transactions ). The Coliseum Stockholders (as defined in the Proxy Statement) own more than 15% of the outstanding

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_21 [2025-04-29 09:29:24 -0400] 1181 Bytes | 298 tokens | Cum: 5753 tkns (71.91% of 8k)
==========================================================================

Showing S4 (chunk 3 of 4): voting stock of the Company and may therefore be deemed collectively to be an interested stockholder (as defined in Section 203 of the Delaware General Corporation Law (the DGCL )) of the Company with respect to the Coliseum Transactions.

First Supplemental Indenture

As previously disclosed by the Company in a Current Report on Form 8-K filed by the Company with the Commission on March 11, 2025, on March 7, 2025, the Company issued $251.0 million of Second Lien Notes pursuant to an indenture (the Second Lien Notes Indenture ), dated as of March 7, 2025, among the Company, the guarantors party thereto (the Guarantors ) and Ankura Trust Company, LLC, as trustee (in such capacity, the Trustee ) and notes collateral agent (in such capacity, the Notes Collateral Agent ). On March 14, 2025, the Company, the Guarantors, the Trustee and the Notes Collateral Agent entered into a supplemental

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_23 [2025-04-29 09:29:25 -0400] 905 Bytes | 211 tokens | Cum: 5966 tkns (74.58% of 8k)
==========================================================================

Showing S4 (chunk 4 of 4): indenture (the First Supplemental Indenture ) to the Second Lien Notes Indenture, pursuant to which the Company issued $50.165 million of Second Lien Notes to the Investors.

The foregoing description of the First Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to the full text of the First Supplemental Indenture, which is attached as Exhibit 4.1 hereto and incorporated herein by reference. Investors and other parties are encouraged to read the full text of the First Supplemental Indenture because it contains other important information not summarized herein....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODV_OUT_25 [2025-04-29 09:29:34 -0400] 6450 Bytes | 1744 tokens | Cum: 7712 tkns (96.40% of 8k)
==========================================================================

This is our set of metrics for ModivCare.
Please analyze the numbers.

+---------------------+------------------------+------------------------+------------------------+
| Volume: 358,783 | Perf Month: -12.50% | Option/Short: Yes / No | Sales Y/Y TTM: 1.32% |
+---------------------+------------------------+------------------------+------------------------+
| Avg Volume: 551.72K | Perf Quarter: -72.55% | Short Float: 20.22% | ROE: -341.96% |
+---------------------+------------------------+------------------------+------------------------+
| Rel Volume: 0.64 | Index: RUT | Short Ratio: 4.38 | ROI: -20.52% |
+---------------------+------------------------+------------------------+------------------------+
| RSI (14): 43.37 | Market Cap: 20.08M | Short Interest: 2.42M | Sales Surprise: -0.07% |
+---------------------+------------------------+------------------------+------------------------+
| ATR (14): 0.27 | Shs Outstand: 14.32M | Beta: 0.86 | EPS Surprise: -62.91% |
+---------------------+------------------------+------------------------+------------------------+
| SMA20: 13.20% | Shs Float: 11.96M | Sales Q/Q: -0.00% | P/E: - |
+---------------------+------------------------+------------------------+------------------------+
| SMA50: -43.08% | Inst Own: 101.38% | Sales past 5Y: 14.63% | Earnings: May 08 AMC |
+---------------------+------------------------+------------------------+------------------------+
| SMA200: -89.29% | Insider Own: 16.59% | Employees: 23675 | |
+---------------------+------------------------+------------------------+------------------------+
| Perf Week: 40.01% | Insider Trans: 223.89% | Debt/Eq: - | |
+---------------------+------------------------+------------------------+------------------------+

The next section covers any insider trading by ModivCare officers or majority shareholders (if available).

No transactions recorded.

No transactions recorded.

No transactions recorded.

No transactions recorded.

Inside Trans: ModivCare Inc (MODV) by AI Catalyst Fund, LP (Unknown Title) on 2025-01-30
- Common Stock, par value $0.001 per share ("Common Stock"): 45000 shares at $4.35 (D)
- Common Stock, par value $0.001 per share ("Common Stock"): 187500 shares at $4.03 (D)
- Common Stock, par value $0.001 per share ("Common Stock"): 187500 shares at $3.87 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 2787586000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -201278000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.4
Average Volume: 517400.5
30-Day High: 1.54
30-Day Low: 0.9859

[Detailed Financials: TTM 2024]
- Total Assets: $1,654,332,000.00
- Total Liabilities: $1,692,806,000.00
- Total Equity: $-38,474,000.00
- Current Assets: $495,379,000.00
- Current Liabilities: $624,494,000.00

[Income Statement: TTM 2024]
- Revenue: $2,787,586,000.00
- Net Income: $-201,278,000.00
- Gross Profit: $420,371,000.00
- Operating Income: $-92,787,000.00
- Earnings Per Share (EPS): -14.14

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $110,334,000.00

[Detailed Financials: FY 2024]
- Total Assets: $1,654,332,000.00
- Total Liabilities: $1,692,806,000.00
- Total Equity: $-38,474,000.00
- Current Assets: $495,379,000.00
- Current Liabilities: $624,494,000.00

[Income Statement: FY 2024]
- Revenue: $2,787,586,000.00
- Net Income: $-201,278,000.00
- Gross Profit: $420,371,000.00
- Operating Income: $-92,787,000.00
- Earnings Per Share (EPS): -14.14

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $110,334,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of ModivCare (MODV).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about ModivCare.

2) MARKET_SCORE[]
This conversation was initiated because MODV is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for MODV.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, MODV could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect MODV to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of ModivCare.

11) ETHICAL_RATING[]
Rate ModivCare’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of ModivCare.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

MODV_IN_27 [2025-04-29 09:29:34 -0400] 126 Bytes | 29 tokens | Cum: 7953 tkns (99.41% of 8k)
==========================================================================

====================================
[2025-04-29 09:29:34] # Analysis Completed
Elapsed Time: 20.25 seconds